Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MPLT
Stock Latest News
Ratings
Analyst Maintains Buy on MapLight Therapeutics, Reaffirms $45 Price Target Ahead of Key Phase 2 ZEPHYR Readout
5d ago
MPLT
Premium
The Fly
MapLight Therapeutics initiated with a Strong Buy at Raymond James
13d ago
MPLT
Premium
Company Announcements
MapLight Shareholders Back Board Slate and Auditor
13d ago
8K
MPLT
Premium
The Fly
MapLight Therapeutics price target lowered to $40 from $43 at Craig-Hallum
14d ago
MPLT
Premium
Ratings
Overweight Rating Reaffirmed on ML004’s Irritability Efficacy and Safety Profile; $34 Price Target Maintained
14d ago
MPLT
Premium
Ratings
Analyst Maintains Buy/Outperform on ML-004’s Safety, Irritability Signal and Pipeline Strength; Price Target Steady at $45
14d ago
MPLT
Premium
Company Announcements
MapLight Reports Phase 2 Data for Autism Candidate
15d ago
8K
MPLT
Premium
The Fly
MapLight Therapeutics announces IRIS trial misses primary endpoint
15d ago
MPLT
Premium
Company Announcements
MapLight Therapeutics Names Interim CFO After HR Review
19d ago
8K
MPLT
Premium
The Fly
MapLight Therapeutics price target raised to $36 from $28 at Stifel
1M ago
MPLT
Premium
The Fly
Eight new option listings and one option delisting on May 28th
1M ago
CEPT
DXYZ
Premium
The Fly
MapLight Therapeutics initiated with a Buy at UBS
1M ago
MPLT
Premium
The Fly
Midday Fly By: Nvidia reports Q1 beat, SpaceX files for IPO
2M ago
DE
KD
Premium
The Fly
Craig-Hallum bullish on MapLight Therapeutics, initiates with a Buy
2M ago
MPLT
Premium
The Fly
MapLight Therapeutics initiated with a Buy at Craig-Hallum
2M ago
MPLT
Premium
Ratings
Analyst Reiterates Buy on MapLight, Maintains $37 Price Target on Confidence in ML-007 and Pipeline Upside
2M ago
MPLT
Premium
Ratings
Buy Rating Reiterated on Clinical Catalysts and Strong Cash Runway; $37 Price Target Unchanged
2M ago
MPLT
Premium
Company Announcements
MapLight Therapeutics Expands Pipeline Amid Rising Quarterly Losses
2M ago
8K
MPLT
Premium
The Fly
MapLight Therapeutics reports Q1 EPS ($1.34), consensus ($1.12)
2M ago
MPLT
Premium
The Fly
MapLight Therapeutics initiated with an Outperform at LifeSci Capital
2M ago
MPLT
Premium
The Fly
MapLight Therapeutics management to meet with Needham
2M ago
MPLT
Premium
The Fly
MapLight Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
MPLT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
